Canaccord Genuity analyst Caitlin Cronin has maintained their bullish stance on KRMD stock, giving a Buy rating on November 14.Don't Miss our ...

Modeled after the state’s $6 billion cancer research fund, the dementia fund — a legislative priority for Lt. Gov. Dan ...

Luke’s would provide an infusion of capital but did not share how much would be added ... Additionally, a team of researchers from THI, BCM and Texas Children’s Hospital secured funding for a new ...

Although the 2015 Baxalta spinoff was successful, Baxter's financial results fell substantially in 2022-23 on external pressures, such as inflation and weak medical utilization trends. With medical ...

Commentary: Social media users correctly spotted my misdiagnosis. Here are two diabetes tech wearables everyone should know ...

MedAware, an AI platform improving patient safety, demonstrates the shift from rule-based systems to data-driven, ...

A large-scale clinical trial found that intravenous infusion of exenatide, a glucagon-like peptide-1 (GLP-1) analog medication, during heart surgeries involving bypass did not significantly reduce the ...

As mentioned last week, the Centers for Medicare & Medicaid Services (CMS) recently put out a large buffet of regs – too many ...

Recent quality and operational issues at Smiths, which originated before it was purchased, greatly reduced ICU’s gross margin after the acquisition. These issues have required additional spending to ...

Key drivers include chronic conditions and an ageing population. An increasing prevalence of chronic diseases is expected to ...

Avanos Medical announced today that a Centers for Medicare and Medicaid Services (CMS) payment rule benefits its infusion ...

Leading medical equipment provider recognized for its ‘people-first culture,’empowering working environment supporting ...